Resonate Capital’s Mesabi Trust MSB Stock Holding History

Resonate Capital’s Portfolio MSB Stock Details MSB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-23,738	Closed	-$627K	–	23
2021 Q4	$627K	Buy	+23,738	New	+$635K	0.55%	22

Other funds holding MSB

HKAM

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

ValueWorks New York $367M AUM 59.38% 1-Year Est. Return

BCM

Beddow Capital Management Jackson, Wyoming $265M AUM 18.36% 1-Year Est. Return

MRI

Mad River Investors Boston, Massachusetts $278M AUM 32.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SIC

SFE Investment Counsel Los Angeles, California $635M AUM 23.85% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Resonate Capital's MSB Position: Q1 2022 in Review

Resonate Capital sold out of Mesabi Trust (MSB) in Q1 2022, closing a stake of 23,738 shares — an estimated $627K sold.

Resonate Capital first reported a position in MSB in Q4 2021 and held it in 1 quarter. The position peaked at $627K in Q4 2021. 57 funds tracked by Wall St. Rank hold MSB as of Q1 2022.

Resonate Capital reported no remaining Mesabi Trust position as of Q1 2022 after selling out during the quarter.
Resonate Capital sold 23,738 Mesabi Trust shares in Q1 2022, an estimated $627K.
Resonate Capital first reported a position in Mesabi Trust in Q4 2021 and held it in 1 quarter.
Resonate Capital's Mesabi Trust position peaked at $627K in Q4 2021.
57 funds tracked by Wall St. Rank held Mesabi Trust as of Q1 2022.

Based on Resonate Capital's 13F filing for Q1 2022, filed 16 May 2022.